AU2021900219A0 - Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use - Google Patents

Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use

Info

Publication number
AU2021900219A0
AU2021900219A0 AU2021900219A AU2021900219A AU2021900219A0 AU 2021900219 A0 AU2021900219 A0 AU 2021900219A0 AU 2021900219 A AU2021900219 A AU 2021900219A AU 2021900219 A AU2021900219 A AU 2021900219A AU 2021900219 A0 AU2021900219 A0 AU 2021900219A0
Authority
AU
Australia
Prior art keywords
mdma
enantiomers
manufacture
pharmaceutical preparations
novel method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021900219A
Inventor
Victor Chiruta
Robert Desmond Renshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octavian and Desmond Pty Ltd
Original Assignee
Octavian and Desmond Pty Ltd
Filing date
Publication date
Application filed by Octavian and Desmond Pty Ltd filed Critical Octavian and Desmond Pty Ltd
Publication of AU2021900219A0 publication Critical patent/AU2021900219A0/en
Pending legal-status Critical Current

Links

AU2021900219A 2021-02-02 Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use Pending AU2021900219A0 (en)

Publications (1)

Publication Number Publication Date
AU2021900219A0 true AU2021900219A0 (en) 2021-02-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP4126879A4 (en) Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use
EP3978496A4 (en) Btk inhibitor ring derivative, preparation method therefor and pharmaceutical application thereof
EP4089084A4 (en) Cannabidiol derivative, and preparation method therefor and medical use thereof
EP4169906A4 (en) Method for synthesis of roxadustat and intermediate thereof, and intermediate thereof
EP4088723A4 (en) Cannabidiol derivative, and preparation method therefor and medical use thereof
EP3954380A4 (en) Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof
EP4058017A4 (en) Drug formulations and methods of treatment for metabolic disorders
EP4056551A4 (en) Crystal form i of curcumin derivative, preparation method therefor and application thereof
AU2021900219A0 (en) Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use
AU2021235467A1 (en) Process for the synthesis of cannabidiol and intermediates thereof
EP4137480A4 (en) Amino acid derivative containing non-steroidal anti-inflammatory drug structure, preparation method therefor and application thereof
EP3960240A4 (en) Pharmaceutical preparation and method for producing same
EP3912985A4 (en) Crystal forms of antidepressant drug sage-217 and preparation method therefor
EP4122922A4 (en) Fused bicyclic derivative, preparation method therefor, and pharmaceutical use thereof
EP4076527A4 (en) Therapeutic combinations of drugs and methods of using them
EP4143202A4 (en) Method of treating ship1-mediated diseases using pelorol derivatives
EP4257121A4 (en) Bladder perfusion pharmaceutical composition, preparation method therefor and application thereof
EP4198017A4 (en) Benzylamine derivative, preparation method therefor and use thereof
EP4137124A4 (en) Solid pharmaceutical preparation, preparation method therefor and use thereof
EP4114410A4 (en) Production of nmn and its derivatives via microbial processes
AU2020904571A0 (en) Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use
EP4005572A4 (en) Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer
EP3946365A4 (en) Liposomal formulations, and methods of using and preparing thereof
EP4067349A4 (en) Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof
EP3903806A4 (en) Pharmaceutical composition for treating trpv1 activity-mediated diseases